The Current Ratio as of September 2024 (TTM) for NovoCure Limited (NVCR) is 6.46

According to NovoCure Limited’s latest financial reports and current stock price. The company's current Current Ratio is 6.46. This represents a change of 2.69% compared to the average of 6.29 of the last 4 quarters.

NovoCure Limited (NVCR) Historical Current Ratio (quarterly & annually)

How has NVCR Current Ratio performed in the past?

The mean historical Current Ratio of NovoCure Limited over the last ten years is 6.78. The current 6.46 Current Ratio has changed 9.43% with respect to the historical average. Over the past ten years (40 quarters), NVCR's Current Ratio was at its highest in in the December 2015 quarter at 10.27. The Current Ratio was at its lowest in in the September 2014 quarter at 0.

NovoCure Limited (NVCR) Current Ratio by Quarter and Year

Discovering the peaks and valleys of NovoCure Limited Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

NovoCure Limited (NVCR) Average Current Ratio

How has NVCR Current Ratio performed in the past?

The current Current Ratio of NovoCure Limited (NVCR) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

NovoCure Limited (NVCR) Current Ratio vs. Peers

How is NVCR’s Current Ratio compared to its peers?

NovoCure Limited’s Current Ratio is less than Globus Medical, Inc. (0), greater than Insulet Corporation (2.42), greater than Inspire Medical Systems, Inc. (3.56), less than Inari Medical, Inc. (9.25), greater than TransMedics Group, Inc. (1.80), less than InMode Ltd. (9.37), less than Integer Holdings Corporation (8.63), greater than CONMED Corporation (3.29), greater than LivaNova PLC (2.34), greater than iRhythm Technologies, Inc. (3.45), less than Heska Corporation (6.92), greater than ShockWave Medical, Inc. (5.64), less than Penumbra, Inc. (13.81), greater than Masimo Corporation (6.25), greater than null (2.09),

Build a custom stock screener for NovoCure Limited (NVCR) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NovoCure Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

NovoCure Limited (NVCR) and other stocks custom spreadsheet templates

The easiest way to analyze a company like NovoCure Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.